Title:
レバミピドを含む関節リューマチの予防用または治療用の薬学組成物
Document Type and Number:
Japanese Patent JP2013503153
Kind Code:
A
Abstract:
The present invention provides a pharmaceutical composition for preventing or treating rheumatoid arthritis comprising rebamipide as an active ingredient and a pharmaceutically acceptable carrier. The pharmaceutical composition may be for oral administration, for example an oral solid dosage form of a tablet or capsule form. The pharmaceutical composition may be formulated into a unit dosage form suitable for orally administering rebamipide in a dose ranging from 0.5 to 50 mg/kg, preferably from 0.6 to 6 mg/kg.
Inventors:
Min, Junki
Cho, Mira
U, Yunju
Oh, Heja
Chun, Juyoung
Lee, Gun Hyuk
Park, Sewan
Park, Jinha
Kwon, Eunyoung
Cho, Mira
U, Yunju
Oh, Heja
Chun, Juyoung
Lee, Gun Hyuk
Park, Sewan
Park, Jinha
Kwon, Eunyoung
Application Number:
JP2012526612A
Publication Date:
January 31, 2013
Filing Date:
October 08, 2009
Export Citation:
Assignee:
Catholic University Industry Academic Co-Operation Foundation
Hanlim Pharmaceutical Company Limited
Hanlim Pharmaceutical Company Limited
International Classes:
A61K31/4704; A61K9/20; A61K9/48; A61P19/02; A61P29/00; C07D215/22
Other References:
JPN6013057173; ＫＯＨＡＳＨＩ， Ｍ． ｅｔ ａｌ．: ＡＲＴＨＲＩＴＩＳ ＆ ＲＨＥＵＭＡＴＩＳＭ Ｖｏｌ．５８， Ｎｏ．２, 2008, ｐ．３８９-４００
JPN6013057175; ＫＡＰＯＯＲ， Ｓ．: ＡＲＴＨＲＩＴＩＳ ＆ ＲＨＥＵＭＡＴＩＳＭ Ｖｏｌ．５８， Ｎｏ．９, 2008, ｐ．２９２３
JPN6013057175; ＫＡＰＯＯＲ， Ｓ．: ＡＲＴＨＲＩＴＩＳ ＆ ＲＨＥＵＭＡＴＩＳＭ Ｖｏｌ．５８， Ｎｏ．９, 2008, ｐ．２９２３
Attorney, Agent or Firm:
Ryu Iwatani